A randomised Phase 3 Trial of ALIMTA and Cisplatin versus GEMZAR and Cisplatin in Patients with locally advanced or metastatic Non-Small-Cell Lung Cancer

Registry ID

EUCTR2004-000028-34

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Eli Lilly and Company Limited

Start date

2004-07-06

Completion date

2008-03-10

Last update

2026-08-16

Conditions

• Locally advanced or metastatic Non-Small Cell Lung Cancer

Summary

To compare ALIMTA plus cisplatin with GEMZAR plus cisplatin in terms of the overall survival of previously untreated patients with Stage IIIB and IV NSCLC.

Locations

• , , Finland
• , , Hungary
• , , Spain
• , , Denmark

Related clinical trials

• A Phase 2, Open-label, Multicohort, Study of Rinatabart Sesutecan (Rina-S) in Participants with Non-Small Cell Lung Cancer

View on source registry